Barely Significant
← all excerpts

The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer.

Cancers (Basel) · 2023 · PMC10670388 · PMID 38001620

Europe PMCDOI
1
hedged sentence
0.0570
closest p · 1.1× alpha
0.0570
boldest claim

The sentences

borderline significancep = 0.057so close (0.05 < p ≤ 0.1)
In the multivariate model, HER2 status (HR = 0.630, p = 0.008), menopausal status (HR = 2.362, p < 0.001), the presence of BRCA1/2 mutations (HR = 3.300, p = 0.01), axillary surgery (HR = 2.091, p = 0.003), adjuvant chemotherapy and radiation therapy (HR = 0.373, p < 0.001 and HR = 2.534, p < 0.001), higher pT and pN stages, and Ki-67 expression exceeding 20% (borderline significance, p = 0.057) remained as significant predictors of OS.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.